Sangamo: 2Q Earnings Snapshot
Posted August 5, 2020 2:34 pm.
Last Updated August 5, 2020 2:48 pm.
This article is more than 5 years old.
BRISBANE, Calif. (AP) _ Sangamo Therapeutics Inc. (SGMO) on Wednesday reported a loss of $35.9 million in its second quarter.
The Brisbane, California-based company said it had a loss of 26 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 41 cents per share.
The drug developer posted revenue of $21.6 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $74.5 million.
Sangamo shares have risen 37% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $11.50, an increase of 2% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO
The Associated Press
